{"id":"https://openalex.org/W2017306702","doi":"https://doi.org/10.1111/j.1365-2133.2003.05584.x","title":"A 6-month prospective survey of cutaneous drug reactions in a hospital setting","display_name":"A 6-month prospective survey of cutaneous drug reactions in a hospital setting","publication_year":2003,"publication_date":"2003-11-01","ids":{"openalex":"https://openalex.org/W2017306702","doi":"https://doi.org/10.1111/j.1365-2133.2003.05584.x","mag":"2017306702","pmid":"https://pubmed.ncbi.nlm.nih.gov/14632808"},"language":"en","primary_location":{"id":"doi:10.1111/j.1365-2133.2003.05584.x","doi":"https://doi.org/10.1111/j.1365-2133.2003.05584.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1365-2133.2003.05584.x","pdf_url":null,"source":{"id":"https://openalex.org/S45720283","display_name":"British Journal of Dermatology","issn_l":"0007-0963","issn":["0007-0963","1365-2133"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Dermatology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5011062550","display_name":"F. Fiszenson-Albala","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210097159","display_name":"Assistance Publique \u2013 H\u00f4pitaux de Paris","ror":"https://ror.org/00pg5jh14","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159"]},{"id":"https://openalex.org/I4210145170","display_name":"H\u00f4pital Bichat-Claude-Bernard","ror":"https://ror.org/03fdnmv92","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210145170"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"F. Fiszenson-Albala","raw_affiliation_strings":["Department of Dermatology, H\u00f4pital Bichat-Claude Bernard, AP-HP, 46 rue Henri Huchard, 75018 Paris, France","Departments of Dermatology, Pharmacy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Dermatology, H\u00f4pital Bichat-Claude Bernard, AP-HP, 46 rue Henri Huchard, 75018 Paris, France","institution_ids":["https://openalex.org/I4210097159","https://openalex.org/I4210145170"]},{"raw_affiliation_string":"Departments of Dermatology, Pharmacy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077213829","display_name":"V. Auzerie","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"V. Auzerie","raw_affiliation_strings":["Departments of Dermatology, Pharmacy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Dermatology, Pharmacy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007427635","display_name":"Emmanuel Mahe\u0301","orcid":"https://orcid.org/0000-0001-5780-1827","observed_orcids":["https://orcid.org/0000-0001-5780-1827"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E. Mahe","raw_affiliation_strings":["Departments of Dermatology, Pharmacy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Dermatology, Pharmacy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071030872","display_name":"Robert Farinotti","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R. Farinotti","raw_affiliation_strings":["Departments of Dermatology, Pharmacy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Dermatology, Pharmacy","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5038988172","display_name":"C. Durand-Stocco","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210145170","display_name":"H\u00f4pital Bichat-Claude-Bernard","ror":"https://ror.org/03fdnmv92","country_code":"FR","type":"healthcare","lineage":["https://openalex.org/I4210097159","https://openalex.org/I4210145170"]}],"countries":["FR"],"is_corresponding":false,"raw_author_name":"C. Durand-Stocco","raw_affiliation_strings":["Public Health, H\u00f4pital Bichat\u2010Claude Bernard, AP\u2010HP, 46 rue Henri Huchard, 75018 Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Public Health, H\u00f4pital Bichat\u2010Claude Bernard, AP\u2010HP, 46 rue Henri Huchard, 75018 Paris, France","institution_ids":["https://openalex.org/I4210145170"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113576299","display_name":"Beatrice Crickx","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"B. Crickx","raw_affiliation_strings":["Departments of Dermatology, Pharmacy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Dermatology, Pharmacy","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5011037498","display_name":"V. Descamps","orcid":"https://orcid.org/0000-0001-6154-005X","observed_orcids":["https://orcid.org/0000-0001-6154-005X","https://orcid.org/0000-0001-6043-6242"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"V. Descamps","raw_affiliation_strings":["Departments of Dermatology, Pharmacy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Dermatology, Pharmacy","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5011037498"],"corresponding_institution_ids":[],"apc_list":{"value":3731,"currency":"GBP","value_usd":4920},"apc_paid":null,"fwci":4.0513,"has_fulltext":false,"cited_by_count":289,"citation_normalized_percentile":{"value":0.9342569,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":96,"max":100},"biblio":{"volume":"149","issue":"5","first_page":"1018","last_page":"1022"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","score":0.9901999831199646,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11117","display_name":"Drug-Induced Adverse Reactions","score":0.9901999831199646,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","score":0.005200000014156103,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11033","display_name":"Contact Dermatitis and Allergies","score":0.002199999988079071,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/adverse-cutaneous-drug-reactions","display_name":"adverse cutaneous drug reactions","score":0.9319999814033508},{"id":"https://openalex.org/keywords/skin-allergy","display_name":"skin allergy","score":0.7400000095367432},{"id":"https://openalex.org/keywords/hospitalized-patients","display_name":"hospitalized patients","score":0.7620000243186951},{"id":"https://openalex.org/keywords/incidence","display_name":"incidence","score":0.7829999923706055},{"id":"https://openalex.org/keywords/preventability","display_name":"preventability","score":0.7289999723434448},{"id":"https://openalex.org/keywords/penicillin","display_name":"penicillin","score":0.8560000061988831},{"id":"https://openalex.org/keywords/antibiotics","display_name":"antibiotics","score":0.7239999771118164},{"id":"https://openalex.org/keywords/hiv-infection","display_name":"HIV infection","score":0.9359999895095825},{"id":"https://openalex.org/keywords/connective-tissue-diseases","display_name":"connective tissue diseases","score":0.9710000157356262},{"id":"https://openalex.org/keywords/viral-hepatitis","display_name":"viral hepatitis","score":0.7670000195503235},{"id":"https://openalex.org/keywords/autoimmune-hepatitis","display_name":"autoimmune hepatitis","score":0.5789999961853027},{"id":"https://openalex.org/keywords/length-of-hospital-stay","display_name":"length of hospital stay","score":0.4339999854564667},{"id":"https://openalex.org/keywords/severity-scores","display_name":"severity scoring","score":0.41999998688697815},{"id":"https://openalex.org/keywords/prospective-surveillance","display_name":"prospective surveillance","score":0.3630000054836273},{"id":"https://openalex.org/keywords/adverse-drug-reaction-reporting-system","display_name":"adverse drug reaction reporting system","score":0.32899999618530273}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9067450165748596},{"id":"https://openalex.org/C188816634","wikidata":"https://www.wikidata.org/wiki/Q2113324","display_name":"Prospective cohort study","level":2,"score":0.6691822409629822},{"id":"https://openalex.org/C61511704","wikidata":"https://www.wikidata.org/wiki/Q1671857","display_name":"Incidence (geometry)","level":2,"score":0.6130343079566956},{"id":"https://openalex.org/C2993432071","wikidata":"https://www.wikidata.org/wiki/Q45959","display_name":"Drug reaction","level":3,"score":0.5906230807304382},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.4926331639289856},{"id":"https://openalex.org/C2780542314","wikidata":"https://www.wikidata.org/wiki/Q45959","display_name":"Adverse drug reaction","level":3,"score":0.4324701428413391},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.3685353100299835},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.3353121876716614},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.32229891419410706},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.08514353632926941},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0},{"id":"https://openalex.org/C120665830","wikidata":"https://www.wikidata.org/wiki/Q14620","display_name":"Optics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003875","descriptor_name":"Drug Eruptions","qualifier_ui":"Q000209","qualifier_name":"etiology","is_major_topic":false},{"descriptor_ui":"D003875","descriptor_name":"Drug Eruptions","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true},{"descriptor_ui":"D003875","descriptor_name":"Drug Eruptions","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D005076","descriptor_name":"Exanthema","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005602","descriptor_name":"France","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":false},{"descriptor_ui":"D006302","descriptor_name":"Health Services Research","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006748","descriptor_name":"Hospital Departments","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006760","descriptor_name":"Hospitalization","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007902","descriptor_name":"Length of Stay","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012307","descriptor_name":"Risk Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":false},{"descriptor_ui":"D015994","descriptor_name":"Incidence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1111/j.1365-2133.2003.05584.x","doi":"https://doi.org/10.1111/j.1365-2133.2003.05584.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1365-2133.2003.05584.x","pdf_url":null,"source":{"id":"https://openalex.org/S45720283","display_name":"British Journal of Dermatology","issn_l":"0007-0963","issn":["0007-0963","1365-2133"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Dermatology","raw_type":"journal-article"},{"id":"pmid:14632808","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/14632808","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The British journal of dermatology","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":14,"referenced_works":["https://openalex.org/W125733027","https://openalex.org/W145429101","https://openalex.org/W1007346275","https://openalex.org/W1568882695","https://openalex.org/W1988845906","https://openalex.org/W1991734190","https://openalex.org/W2010993971","https://openalex.org/W2017306147","https://openalex.org/W2170011448","https://openalex.org/W2258724148","https://openalex.org/W2348528624","https://openalex.org/W2400567625","https://openalex.org/W2489062335","https://openalex.org/W4243052123"],"related_works":["https://openalex.org/W125733027","https://openalex.org/W2070817242","https://openalex.org/W2077025580","https://openalex.org/W4226031500","https://openalex.org/W2070483777","https://openalex.org/W176545233","https://openalex.org/W7120300600","https://openalex.org/W4400787008","https://openalex.org/W2052008987","https://openalex.org/W2157823818"],"abstract_inverted_index":{"BACKGROUND:":[0],"Few":[1],"prospective":[2,25],"studies":[3,354,385],"are":[4],"available":[5],"on":[6],"the":[7,12,38,58,104,161,165,169,175,187,295,336,338,434,456],"incidence":[8,39,351,358],"and":[9,62,68,158,172,184,190,236,254,430,448],"analysis":[10],"of":[11,14,40,50,91,98,160,174,199,233,285,297,319,331,335,359,361,423,436,443,458,462],"characteristics":[13,49,150,173],"adverse":[15,59,170,371,424],"cutaneous":[16,41,53,60,74,119,272,362,372,425],"drug":[17,54,65,155,162,188,269,273,363,410],"reactions":[18,43,75,121,274,364,373,426,445],"in":[19,29,211,214,219,231,283,317,329,365,380,389,394,432],"hospital":[20,31],"settings.":[21],"OBJECTIVES:":[22],"A":[23,133,180,197,439],"6-month":[24,83],"study":[26,48,102,347],"was":[27,93,113,136,204,209,315,323,340,446],"managed":[28],"our":[30],"among":[32,201],"hospitalized":[33,202,213,366,392],"patients":[34,51,203,212,391],"to:":[35],"(i)":[36],"evaluate":[37,64],"allergic":[42,73,120,370],"from":[44],"systemic":[45,77,124,376],"drugs;":[46],"(ii)":[47],"with":[52],"reactions;":[55,61],"(iii)":[56],"describe":[57],"(iv)":[63],"reaction":[66,177],"imputability":[67,189,313,435],"preventability.":[69,191],"METHODS:":[70],"All":[71],"suspected":[72,118],"to":[76,87,103,326,342,428],"drugs":[78,125,307,377],"were":[79,117,195,228,275,280,289,301,308,378,386,450],"collected":[80,379],"during":[81,131,164],"a":[82,106,139,143,266,349,415,437],"period":[84],"(November":[85],"2000":[86],"May":[88],"2001).":[89],"Exhaustivity":[90],"recording":[92],"ensured":[94],"by":[95,111,123,138,375],"regular":[96],"dissemination":[97],"information":[99,147],"about":[100,408],"this":[101,381],"practitioners;":[105],"simple":[107],"method":[108],"for":[109,127,291],"inclusion":[110],"fax":[112],"established.":[114],"Inclusion":[115],"criteria":[116],"induced":[122,374],"responsible":[126,290],"hospitalization":[128,292,298],"or":[129,256,300,398],"developed":[130],"hospitalization.":[132],"physical":[134],"examination":[135],"done":[137,388],"dermatologist":[140],"who":[141],"completed":[142],"standardized":[144],"questionnaire.":[145],"Requested":[146],"included":[148],"patient":[149],"(associated":[151],"disorders,":[152],"severity":[153],"score),":[154],"intake":[156,163],"(list":[157],"chronology":[159],"3":[166],"weeks":[167],"preceding":[168],"reaction)":[171],"skin":[176,409],"(type,":[178],"course).":[179],"group":[181],"comprising":[182],"dermatologists":[183],"pharmacologists":[185],"evaluated":[186],"RESULTS:":[192],"Forty-eight":[193],"cases":[194,227,286],"collected.":[196],"prevalence":[198,207,422],"3.6/1000":[200],"estimated.":[205],"The":[206,226,238,383],"rate":[208],"higher":[210],"medical":[215,399],"departments":[216,221,232],"(0.5%)":[217],"than":[218,352],"surgical":[220],"(0.01%)":[222],"(P":[223,418],"<":[224,419],"0.001).":[225],"mostly":[229],"recruited":[230],"infectious":[234],"diseases":[235],"dermatology.":[237],"most":[239],"frequent":[240],"associated":[241],"disorders":[242],"were:":[243],"human":[244],"immunodeficiency":[245],"virus":[246],"(HIV)":[247],"infection":[248,413],"(19%),":[249],"connective":[250],"tissue":[251],"disease":[252],"(10%)":[253],"viral":[255],"autoimmune":[257],"hepatitis":[258],"(12%).":[259],"Of":[260],"these":[261,444,452],"patients,":[262,367],"31%":[263],"had":[264,265],"previous":[267,384],"immunological":[268],"reaction.":[270],"Adverse":[271],"principally":[276,387],"exanthematous":[277],"(56%).":[278],"Reactions":[279],"considered":[281,341],"severe":[282,447],"34%":[284],"because":[287],"they":[288],"(18%),":[293],"increased":[294],"duration":[296],"(14%)":[299],"life":[302],"threatening":[303],"(2%).":[304],"Principal":[305],"imputable":[306],"antibiotics,":[309,429],"mainly":[310],"penicillins.":[311],"An":[312],"score":[314],"likely":[316],"56%":[318],"cases,":[320,337],"but":[321,368],"it":[322],"only":[324,369,393],"possible":[325],"conclude":[327],"definitively":[328],"44%":[330],"patients.":[332],"In":[333],"15%":[334,449],"side-effect":[339],"be":[343],"preventable.":[344],"CONCLUSIONS:":[345],"This":[346],"finds":[348],"lower":[350],"other":[353],"that":[355],"reported":[356],"an":[357,459],"2%":[360],"study.":[382],"selected":[390],"general":[395],"internal":[396],"medicine":[397],"divisions.":[400],"Our":[401],"results":[402],"confirm":[403],"some":[404],"data":[405],"already":[406],"known":[407],"reactions:":[411],"HIV":[412],"as":[414],"risk":[416],"factor":[417],"0.0001),":[420],"high":[421,440],"due":[427],"difficulty":[431],"ascertaining":[433],"drug.":[438],"proportion":[441],"(34%)":[442],"avoidable;":[451],"two":[453],"facts":[454],"justify":[455],"development":[457],"intensive":[460],"programme":[461],"clinical":[463],"pharmacology.":[464]},"counts_by_year":[{"year":2026,"cited_by_count":3},{"year":2025,"cited_by_count":7},{"year":2024,"cited_by_count":17},{"year":2023,"cited_by_count":10},{"year":2022,"cited_by_count":10},{"year":2021,"cited_by_count":12},{"year":2020,"cited_by_count":14},{"year":2019,"cited_by_count":19},{"year":2018,"cited_by_count":12},{"year":2017,"cited_by_count":32},{"year":2016,"cited_by_count":16},{"year":2015,"cited_by_count":15},{"year":2014,"cited_by_count":15},{"year":2013,"cited_by_count":16},{"year":2012,"cited_by_count":17}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}